Navigation Links
Additional Radiotheraphy for Breast Cancer

Research says that giving extra radiotherapy to patients with early breast cancer significantly reduces the risk of cancer recurring in the breast. //The results were so clear that clinical practice should be changed immediately, particularly for younger women.

Nearly five thousand patients took part in the study. The majority of patients had undergone complete removal of their tumor. All the patients had 50Gy radiation to the whole breast and were randomised to receive either a 16Gy boost localised to the tumour bed area or no further radiotherapy. After a follow-up of over five years, only 109 patients in the booster group had suffered a recurrence.

It demonstrates clearly that a 16Gy boost significantly improves local control. Patients who had the boost had an overall local control rate of 95%, and survival at five years was 91%. The largest benefit was seen in women aged under 40, where the chances of recurrence were cut by 54%. Patients will be followed up for many years to see whether booster doses will also cut mortality.

These impressive results mean that a boost should now be considered the standard treatment for early breast cancer, particularly in younger women.
'"/>




Page: 1

Related medicine news :

1. Adding An Additional Drug May Help Patients With Glaucoma
2. Additional Responsiblities To Be Taken Up By Allied Healthcare Professionals
3. No More Additional Cases of Mad Cow Disease in Canada
4. NACO to Introduce 400 Additional AIDS/HIV Screening Centers
5. Analysis Shows Lamictal As An Effective Additional Therapy For Treatment of Grand Mal Seizures
6. Pressing Need for Additional Staff Consultants at NHS
7. NACO Inaugurates 37 Additional HIV Treatment Centers
8. Is Evidence-based Medicine Enough to Support Additional Research in Alternative Medicine?
9. Additional Research Imperative on Lung Cancer in Women
10. AIIMS Director Venugopal Removed from Additional Post
11. Consensus on "Combination Therapy" for Breast Cancer
Post Your Comments:
(Date:7/25/2008)...stCall/ -- Thoratec,Corporation (Nasdaq: THOR ) a...ry support therapies to save, support and restore ...t its operating results for the second,quarter and... 31., The company will hold a conference call to ...ties to all interested parties at 1:30 p.m.,Pacif...
(Date:7/25/2008)...or obese is not only a personal issue that affects...at impacts other people in society. A new study in...at the extra Medicare cost associated with overwei...cial burden on tax payers, costing up to hundreds ...edicare population. , The article,s findings sh...
(Date:7/25/2008)...y.com announces the,availability of Trade Alerts o...ll of the daily trading notes for free by visiting...ts include: DUSA Pharmaceuticals Inc. (Nasdaq: DU...BRK ), NovaMed Inc. (Nasdaq:,NOVA), Adolor Corp. (...and,Abaxis Inc. (Nasdaq: ABAX )., Join investor ...
(Date:7/25/2008)...ense and Federal Agencies in, the execution of Op...s a, four-day, multi-agency collaborative traini...cal agencies with large and complex incident respo...d-hoc, secure mobile communications infrastructu... Va., July 25 /PRNewswire/ -- Dataline LLC is plea...
Breaking Medicine News(10 mins):Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3
...to that apple or lentils, for a new study has foun...lowly once they have been consumed helps dieters l...ood sugar levels. Foods that release sugars rapid... index - those that release it slowly have a low g...
...mours once again when she was pictured with baby b...re of John Travolta starrer Hairspray dressed in a... her bump, reports the Daily Mail. Holmes sparked...nd hubby Tom Cruise were expecting their second ch...
...t a government-run district hospital in Chhattisga...grawal told the state assembly Tuesday . Amid prot...mbers about the lack of basic medical facilities a...spital in Raigarh district had reported 424 deaths...
...mulation models suggests that the lifetime risk of... computed tomography (CT scan) coronary angiograph...nd younger patients. Coronary artery disease (CAD...and women in the United States, accounting for 1 i...
Other Medicine News:Health News:Apples and Lentils Could Help You to Shed Off Those Extra Pounds! 2Health News:CT Scan Radiations may Lead to Cancer 2
(Date:7/23/2008)... WASHINGTON, July 23 /PRNewswire-USNewswire/ ...nt of Justice:, Chairman Conyers, Ranking Member ... the opportunity to testify today., Since I appea... have,become even better acquainted with the talen...artment and with the work they do, and I have come...
(Date:7/23/2008)... SEATTLE, July 23 /- D...ed that it expects the Independent Data,Monitoring...terim analysis,of overall survival relating to the...ate AdenoCarcinoma Treatment, also known as D9902B...OVENGE is the Company,s investigational,active cel...
(Date:7/22/2008)... MINNEAPOLIS, July 22 /- Nonin M...oring solutions for more than 20 years, has entere... technology to measure,regional oxygen saturation....gy is the continuous monitoring of the regional bl..., Early testing data and outcomes from an ongoing...
(Date:7/22/2008)... - State-of-the-Art PET Study Confirms Tyrima Ex... Properties - - Results Support Initiat...GLE PARK, N.C., July 22 /- CeNeRx Bio...and commercializing innovative,treatments for dise...d,plans to advance its lead candidate Tyrima(TM) i...
Breaking Medicine Technology:Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Bottom trawling impacts clearly visible from space 2221 1Bottom trawling impacts clearly visible from space 2221 2Bottom trawling impacts clearly visible from space 2221 3Dr Welsh Self Test Diagnoses Glaucoma the Leading Cause of Preventable Blindness 12056 1Dr Welsh Self Test Diagnoses Glaucoma the Leading Cause of Preventable Blindness 12056 2DentaBurst 28TM 29 Freshening Teeth Cleaners Launches Outshine Everyone Video Contest 12052 1DentaBurst 28TM 29 Freshening Teeth Cleaners Launches Outshine Everyone Video Contest 12052 2Moving beyond tamoxifen 3A Drug discovery and the future of selective hormone receptor modulators 12049 1Moving beyond tamoxifen 3A Drug discovery and the future of selective hormone receptor modulators 12049 2
...ontributing Editor , ,Appendicitis is a co... of individuals sometime in their lives. The cond...ntestine at the proximal colon, becomes obstructed...ensues, which can rapidly evolve to perforation an...y elevated for children and those over 50, rises a...
... Human papillomaviruses (HPVs) are small, closed c...sified by nucleic acid sequence homology rather th...t prevalent sexually transmitted pathogens. Of th...mited number of high and intermediate risk types d...rldwide, HPV has been associated with 99.7% of squ...
Other Medicine Technology:Appendicitis: Evolving Tools to Diagnose a Classic Disease 2Appendicitis: Evolving Tools to Diagnose a Classic Disease 3Testing for Human Papillomavirus 2Testing for Human Papillomavirus 3
Curved shafts and tips with 6 mm tying platform. Wide serrated handle with dull finish. Overall length 4.3 inches.
Curved shafts and tips with 5.5 mm tying platform. 0.3 mm gap at platform heel. True round knurled handle in closed position with polished finish. Overall length 4.3 inches.
5 mm tying platform. Round knurled handle with dull finish. Curved shafts. Overall length 3.9 inches.
Slightly curved 10 mm jaws and serrated cross action handle with polished finish. Overall length 4.6 inches.
Medicine Products: